Quick Answer
CytomX Therapeutics, Inc. reported Shares Outstanding of 170.19 million shares for fiscal year 2025.
CytomX Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 170.19M | +112.5% |
| 2024 | 80.10M | +19.0% |
| 2023 | 67.31M | +1.6% |
| 2022 | 66.23M | +1.3% |
| 2021 | 65.39M | +35.5% |
| 2020 | 48.25M | +6.0% |
| 2019 | 45.52M | +1.0% |
| 2018 | 45.08M | +17.2% |
| 2017 | 38.48M | +5.4% |
| 2016 | 36.49M | +1.3% |
| 2015 | 36.03M | +0.0% |
| 2015 | 36.03M | +3515.9% |
| 2014 | 996,520 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | 65.95M | +1.1% | +0.3% |
| June 30, 2022 | 65.76M | +0.9% | +0.5% |
| March 31, 2022 | 65.40M | +0.6% | +0.0% |
| December 31, 2021 | 65.39M | +35.5% | +0.2% |
| September 30, 2021 | 65.25M | +41.2% | +0.1% |
| June 30, 2021 | 65.16M | +41.1% | +0.2% |
| March 31, 2021 | 65.00M | +41.6% | +34.7% |
| December 31, 2020 | 48.25M | +6.0% | +4.4% |
- CytomX Therapeutics, Inc. showed an increase of +112.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, CytomX Therapeutics, Inc.’s shares outstanding has grown by 16978.1% (from 996.5 thousand shares to 170.19 million shares).
- The most recent figure is from CytomX Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: